| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity
|
Fukuiwa, Tatsuya
|
|
2008
|
26 |
Supplement 2 |
p. 4849-4859
11 p.
|
artikel
|
| 2 |
Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease
|
Furumoto, Akitsugu
|
|
2008
|
26 |
Supplement 2 |
p. 4284-4289
6 p.
|
artikel
|
| 3 |
A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is genetically stable in vitro and in vivo
|
Gillespie, J.
|
|
2008
|
26 |
Supplement 2 |
p. 4231-4236
6 p.
|
artikel
|
| 4 |
Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998–2004
|
Sebastian, R.
|
|
2008
|
26 |
Supplement 2 |
p. 1397-1403
7 p.
|
artikel
|
| 5 |
A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus
|
Abel, Kristina
|
|
2008
|
26 |
Supplement 2 |
p. 6013-6025
13 p.
|
artikel
|
| 6 |
A local reaction at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Gidudu, Jane
|
|
2008
|
26 |
Supplement 2 |
p. 6800-6813
14 p.
|
artikel
|
| 7 |
Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2
|
Svane, Inge Marie
|
|
2008
|
26 |
Supplement 2 |
p. 4716-4724
9 p.
|
artikel
|
| 8 |
A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2
|
Tsuji, Takao
|
|
2008
|
26 |
Supplement 2 |
p. 2092-2099
8 p.
|
artikel
|
| 9 |
A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria
|
Malkin, Elissa
|
|
2008
|
26 |
Supplement 2 |
p. 6864-6873
10 p.
|
artikel
|
| 10 |
A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus
|
Schulze, Kai
|
|
2008
|
26 |
Supplement 2 |
p. 6678-6684
7 p.
|
artikel
|
| 11 |
A recombinant plasmid co-expressing swine ubiquitin and the GP5 encoding-gene of porcine reproductive and respiratory syndrome virus induces protective immunity in piglets
|
Hou, Yan-Hong
|
|
2008
|
26 |
Supplement 2 |
p. 1438-1449
12 p.
|
artikel
|
| 12 |
A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection
|
Chua, Brendon Y.
|
|
2008
|
26 |
Supplement 2 |
p. 4866-4875
10 p.
|
artikel
|
| 13 |
Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results
|
Dhiman, Neelam
|
|
2008
|
26 |
Supplement 2 |
p. 1731-1736
6 p.
|
artikel
|
| 14 |
Attenuated West Nile viruses bearing 3′SL and envelope gene substitution mutations
|
Yu, Li
|
|
2008
|
26 |
Supplement 2 |
p. 5981-5988
8 p.
|
artikel
|
| 15 |
A vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens
|
Sakabe, Saori
|
|
2008
|
26 |
Supplement 2 |
p. 2127-2134
8 p.
|
artikel
|
| 16 |
A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses
|
Sohn, Young Mo
|
|
2008
|
26 |
Supplement 2 |
p. 1638-1643
6 p.
|
artikel
|
| 17 |
Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula)
|
Walcher, Petra
|
|
2008
|
26 |
Supplement 2 |
p. 6832-6838
7 p.
|
artikel
|
| 18 |
c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection
|
Ogunniyi, Abiodun D.
|
|
2008
|
26 |
Supplement 2 |
p. 4676-4685
10 p.
|
artikel
|
| 19 |
Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
|
Guy, Bruno
|
|
2008
|
26 |
Supplement 2 |
p. 5712-5721
10 p.
|
artikel
|
| 20 |
Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration
|
Frič, Jan
|
|
2008
|
26 |
Supplement 2 |
p. 3242-3251
10 p.
|
artikel
|
| 21 |
Cellular and humoral responses to tetanus vaccination in gabonese children
|
van Riet, E.
|
|
2008
|
26 |
Supplement 2 |
p. 3690-3695
6 p.
|
artikel
|
| 22 |
Cervical cancer vaccination: The real meaning of cross-protection and its impact on the prevention
|
De Carvalho, Newton Sergio
|
|
2008
|
26 |
Supplement 2 |
p. 6293-6294
2 p.
|
artikel
|
| 23 |
Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry
|
Wang, L.
|
|
2008
|
26 |
Supplement 2 |
p. 3580-3586
7 p.
|
artikel
|
| 24 |
Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis
|
Yin, Ying
|
|
2008
|
26 |
Supplement 2 |
p. 5814-5821
8 p.
|
artikel
|
| 25 |
Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge
|
Marriott, Kathleen A.
|
|
2008
|
26 |
Supplement 2 |
p. 581-588
8 p.
|
artikel
|
| 26 |
Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity
|
Hamdy, Samar
|
|
2008
|
26 |
Supplement 2 |
p. 5046-5057
12 p.
|
artikel
|
| 27 |
Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques
|
Hirao, Lauren A.
|
|
2008
|
26 |
Supplement 2 |
p. 3112-3120
9 p.
|
artikel
|
| 28 |
Comparative assessment of a metabolically attenuated Mycoplasma gallisepticum mutant as a live vaccine for the prevention of avian respiratory mycoplasmosis
|
Gates, A.E.
|
|
2008
|
26 |
Supplement 2 |
p. 2010-2019
10 p.
|
artikel
|
| 29 |
Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children
|
Givon-Lavi, Noga
|
|
2008
|
26 |
Supplement 2 |
p. 5798-5801
4 p.
|
artikel
|
| 30 |
Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs
|
Hoshino, Yo
|
|
2008
|
26 |
Supplement 2 |
p. 4034-4040
7 p.
|
artikel
|
| 31 |
Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants
|
Gatchalian, Salvacion
|
|
2008
|
26 |
Supplement 2 |
p. 2234-2241
8 p.
|
artikel
|
| 32 |
Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold-adapted vaccine versus DNA prime-adenovirus boost strategies
|
Lo, Chia-Yun
|
|
2008
|
26 |
Supplement 2 |
p. 2062-2072
11 p.
|
artikel
|
| 33 |
Complete protection of cats against feline panleukopenia virus challenge by a recombinant canine adenovirus type 2 expressing VP2 from FPV
|
Yang, Songtao
|
|
2008
|
26 |
Supplement 2 |
p. 1482-1487
6 p.
|
artikel
|
| 34 |
Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum
|
Xie, Yong
|
|
2008
|
26 |
Supplement 2 |
p. 3452-3460
9 p.
|
artikel
|
| 35 |
Cost-effectiveness of adult pertussis vaccination in Germany
|
Lee, Grace M.
|
|
2008
|
26 |
Supplement 2 |
p. 3673-3679
7 p.
|
artikel
|
| 36 |
CpG motif-based adjuvant as a replacement for Freund's complete adjuvant in a recombinant LHRH vaccine
|
Conforti, Valéria A.
|
|
2008
|
26 |
Supplement 2 |
p. 907-913
7 p.
|
artikel
|
| 37 |
Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
|
Ansaldi, Filippo
|
|
2008
|
26 |
Supplement 2 |
p. 1525-1529
5 p.
|
artikel
|
| 38 |
CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine
|
Eliasson, Dubravka Grdic
|
|
2008
|
26 |
Supplement 2 |
p. 1243-1252
10 p.
|
artikel
|
| 39 |
Development and immunogenicity of recombinant Mycoplasma gallisepticum vaccine strain ts-11 expressing chicken IFN-γ
|
Muneta, Yoshihiro
|
|
2008
|
26 |
Supplement 2 |
p. 5449-5454
6 p.
|
artikel
|
| 40 |
Development of a porcine reproductive and respiratory syndrome virus differentiable (DIVA) strain through deletion of specific immunodominant epitopes
|
de Lima, Marcelo
|
|
2008
|
26 |
Supplement 2 |
p. 3594-3600
7 p.
|
artikel
|
| 41 |
Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2
|
Pan, Qunxing
|
|
2008
|
26 |
Supplement 2 |
p. 2119-2126
8 p.
|
artikel
|
| 42 |
Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes
|
Srivastava, Indresh
|
|
2008
|
26 |
Supplement 2 |
p. 2796-2806
11 p.
|
artikel
|
| 43 |
Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada and Australia
|
Shefer, Abigail
|
|
2008
|
26 |
Supplement 2 |
p. K68-K75
nvt p.
|
artikel
|
| 44 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 2 |
p. CO2-
1 p.
|
artikel
|
| 45 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 2 |
p. CO2-
1 p.
|
artikel
|
| 46 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 2 |
p. CO2-
1 p.
|
artikel
|
| 47 |
Editorial Board/Aims and Scope
|
|
|
2008
|
26 |
Supplement 2 |
p. CO2-
1 p.
|
artikel
|
| 48 |
Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway
|
Vestrheim, Didrik F.
|
|
2008
|
26 |
Supplement 2 |
p. 3277-3281
5 p.
|
artikel
|
| 49 |
Effectiveness of a physician peer educator in improving the quality of immunization services for young children in primary care practices
|
Taylor, James A.
|
|
2008
|
26 |
Supplement 2 |
p. 4256-4261
6 p.
|
artikel
|
| 50 |
Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine
|
Liu, Ye
|
|
2008
|
26 |
Supplement 2 |
p. 5368-5372
5 p.
|
artikel
|
| 51 |
Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant
|
Cataldi, Angel
|
|
2008
|
26 |
Supplement 2 |
p. 5662-5667
6 p.
|
artikel
|
| 52 |
Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed
|
Takagi, Hidenori
|
|
2008
|
26 |
Supplement 2 |
p. 6027-6030
4 p.
|
artikel
|
| 53 |
Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26kDa GST plasmid DNA vaccine in mice
|
Wei, Feng
|
|
2008
|
26 |
Supplement 2 |
p. 4145-4149
5 p.
|
artikel
|
| 54 |
Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes
|
Saade, Fadi
|
|
2008
|
26 |
Supplement 2 |
p. 5159-5164
6 p.
|
artikel
|
| 55 |
Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope
|
Mok, Hoyin
|
|
2008
|
26 |
Supplement 2 |
p. 4775-4782
8 p.
|
artikel
|
| 56 |
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
|
Bosch, F. Xavier
|
|
2008
|
26 |
Supplement 2 |
p. K1-K16
nvt p.
|
artikel
|
| 57 |
Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: Implications for introducing PorA based vaccines
|
Pace, David
|
|
2008
|
26 |
Supplement 2 |
p. 5952-5956
5 p.
|
artikel
|
| 58 |
European Sero-Epidemiology Network 2: Standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations
|
Giammanco, Anna
|
|
2008
|
26 |
Supplement 2 |
p. 4486-4493
8 p.
|
artikel
|
| 59 |
Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters
|
Faisal, Syed M.
|
|
2008
|
26 |
Supplement 2 |
p. 277-287
11 p.
|
artikel
|
| 60 |
Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women
|
Kemp, Troy J.
|
|
2008
|
26 |
Supplement 2 |
p. 3608-3616
9 p.
|
artikel
|
| 61 |
Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals
|
von Teichman, Beate F.
|
|
2008
|
26 |
Supplement 2 |
p. 5014-5021
8 p.
|
artikel
|
| 62 |
Evaluation of the potential of synthetic peptides of 80kDa human sperm antigen (80kDaHSA) for the development of contraceptive vaccine for male
|
Khobarekar, Bharati Gangaram
|
|
2008
|
26 |
Supplement 2 |
p. 3711-3718
8 p.
|
artikel
|
| 63 |
Evaluation of widely consumed botanicals as immunological adjuvants
|
Ragupathi, Govind
|
|
2008
|
26 |
Supplement 2 |
p. 4860-4865
6 p.
|
artikel
|
| 64 |
EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
|
McCormack, Sheena
|
|
2008
|
26 |
Supplement 2 |
p. 3162-3174
13 p.
|
artikel
|
| 65 |
Expression and purification of a Plasmodium vivax antigen – PvTARAg55 tryptophan- and alanine-rich antigen and its immunological responses in human subjects
|
Siddiqui, Asim A.
|
|
2007
|
26 |
Supplement 2 |
p. 96-107
12 p.
|
artikel
|
| 66 |
Gender-specific effects of cytokine gene polymorphisms on childhood vaccine responses
|
Baynam, Gareth
|
|
2008
|
26 |
Supplement 2 |
p. 3574-3579
6 p.
|
artikel
|
| 67 |
“Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: Summary of a World Health Organization Technical Consultation
|
Edelman, Robert
|
|
2008
|
26 |
Supplement 2 |
p. 4113-4119
7 p.
|
artikel
|
| 68 |
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
|
Goldie, Sue J.
|
|
2008
|
26 |
Supplement 2 |
p. 4080-4093
14 p.
|
artikel
|
| 69 |
HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response
|
Starodubova, Elizaveta S.
|
|
2008
|
26 |
Supplement 2 |
p. 5170-5176
7 p.
|
artikel
|
| 70 |
H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses
|
Mahmood, Kutubuddin
|
|
2008
|
26 |
Supplement 2 |
p. 5393-5399
7 p.
|
artikel
|
| 71 |
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
|
Joura, Elmar A.
|
|
2008
|
26 |
Supplement 2 |
p. 6844-6851
8 p.
|
artikel
|
| 72 |
Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines
|
Axelsson, Fredrika
|
|
2007
|
26 |
Supplement 2 |
p. 41-46
6 p.
|
artikel
|
| 73 |
Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis
|
Khan, Arif Azam
|
|
2008
|
26 |
Supplement 2 |
p. 316-332
17 p.
|
artikel
|
| 74 |
Immune responses of recombinant adenoviruses expressing immunodominant epitopes against Japanese encephalitis virus
|
Li, Peng
|
|
2008
|
26 |
Supplement 2 |
p. 5802-5807
6 p.
|
artikel
|
| 75 |
Immunization with a DNA vaccine cocktail induces a Th1 response and protects mice against Mycobacterium avium subsp. paratuberculosis challenge
|
Park, Sung-Un
|
|
2008
|
26 |
Supplement 2 |
p. 4329-4337
9 p.
|
artikel
|
| 76 |
Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy
|
Valor, L.
|
|
2008
|
26 |
Supplement 2 |
p. 2738-2745
8 p.
|
artikel
|
| 77 |
Immunization with hybrid recombinant Mycobacterium tuberculosis H37Rv proteins increases the TH1 cytokine response in mice following a pulmonary instillation of irradiated mycobacteria
|
Walton, Chad B.
|
|
2008
|
26 |
Supplement 2 |
p. 4396-4402
7 p.
|
artikel
|
| 78 |
Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge
|
Chung, Yao-Chi
|
|
2008
|
26 |
Supplement 2 |
p. 1855-1862
8 p.
|
artikel
|
| 79 |
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3
|
Gartner, Tatiana
|
|
2008
|
26 |
Supplement 2 |
p. 1458-1470
13 p.
|
artikel
|
| 80 |
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia
|
Saaka, M.
|
|
2008
|
26 |
Supplement 2 |
p. 3719-3726
8 p.
|
artikel
|
| 81 |
Immunogenicity assay of the Leishmune® vaccine against canine visceral leishmaniasis in Brazil
|
Borja-Cabrera, G.P.
|
|
2008
|
26 |
Supplement 2 |
p. 4991-4997
7 p.
|
artikel
|
| 82 |
Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population
|
Leach, Amanda J.
|
|
2008
|
26 |
Supplement 2 |
p. 3885-3891
7 p.
|
artikel
|
| 83 |
Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles
|
Lalitha, P.V.
|
|
2008
|
26 |
Supplement 2 |
p. 4526-4535
10 p.
|
artikel
|
| 84 |
Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis
|
Carrillo, Eugenia
|
|
2008
|
26 |
Supplement 2 |
p. 1902-1911
10 p.
|
artikel
|
| 85 |
Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa–IPV–HBV–Hib combination vaccine in healthy infants
|
Olivier, C.
|
|
2008
|
26 |
Supplement 2 |
p. 3142-3152
11 p.
|
artikel
|
| 86 |
Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis
|
West, Nicholas P.
|
|
2008
|
26 |
Supplement 2 |
p. 3853-3859
7 p.
|
artikel
|
| 87 |
Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams
|
Muñoz, Pilar-María
|
|
2008
|
26 |
Supplement 2 |
p. 2562-2569
8 p.
|
artikel
|
| 88 |
Importance of the major Fli C antigenic site of Salmonella enteritidis as a subunit vaccine antigen
|
Toyota-Hanatani, Yukiko
|
|
2008
|
26 |
Supplement 2 |
p. 4135-4137
3 p.
|
artikel
|
| 89 |
Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus
|
Martinon, Frédéric
|
|
2008
|
26 |
Supplement 2 |
p. 532-545
14 p.
|
artikel
|
| 90 |
Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen
|
Mettens, Pascal
|
|
2008
|
26 |
Supplement 2 |
p. 1072-1082
11 p.
|
artikel
|
| 91 |
Improving the cellular pertussis vaccine: Increased potency and consistency
|
Thalen, Marcel
|
|
2008
|
26 |
Supplement 2 |
p. 653-663
11 p.
|
artikel
|
| 92 |
Inactivated rotavirus vaccines: A priority for accelerated vaccine development
|
Jiang, Baoming
|
|
2008
|
26 |
Supplement 2 |
p. 6754-6758
5 p.
|
artikel
|
| 93 |
Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen
|
Sim, Adrian C.N.
|
|
2008
|
26 |
Supplement 2 |
p. 1145-1154
10 p.
|
artikel
|
| 94 |
Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults
|
Chen, Meng
|
|
2008
|
26 |
Supplement 2 |
p. 4962-4968
7 p.
|
artikel
|
| 95 |
Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants
|
Hu, Yali
|
|
2008
|
26 |
Supplement 2 |
p. 6064-6067
4 p.
|
artikel
|
| 96 |
Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel
|
Swartz, T.A.
|
|
2008
|
26 |
Supplement 2 |
p. 1083-1090
8 p.
|
artikel
|
| 97 |
Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone
|
Bhavanam, Sudha
|
|
2008
|
26 |
Supplement 2 |
p. 6165-6172
8 p.
|
artikel
|
| 98 |
Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+ T-cell responses in the lung
|
Hashimoto, Dai
|
|
2008
|
26 |
Supplement 2 |
p. 5095-5100
6 p.
|
artikel
|
| 99 |
Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement
|
Andrus, Jon Kim
|
|
2008
|
26 |
Supplement 2 |
p. K87-K92
nvt p.
|
artikel
|
| 100 |
Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine
|
Fei-fei, Ge
|
|
2008
|
26 |
Supplement 2 |
p. 5590-5594
5 p.
|
artikel
|
| 101 |
Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age
|
Poovorawan, Yong
|
|
2008
|
26 |
Supplement 2 |
p. 1535-1540
6 p.
|
artikel
|
| 102 |
Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers
|
Littmann, Martina
|
|
2008
|
26 |
Supplement 2 |
p. 2344-2349
6 p.
|
artikel
|
| 103 |
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51
|
Schuller, E.
|
|
2008
|
26 |
Supplement 2 |
p. 4382-4386
5 p.
|
artikel
|
| 104 |
Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization
|
Gudmundsdotter, Lindvi
|
|
2008
|
26 |
Supplement 2 |
p. 5107-5110
4 p.
|
artikel
|
| 105 |
Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant
|
Bråve, Andreas
|
|
2008
|
26 |
Supplement 2 |
p. 5957-5966
10 p.
|
artikel
|
| 106 |
Mathematical Models of Cervical Cancer Prevention in Latin America and the Caribbean
|
Goldie, Sue J.
|
|
2008
|
26 |
Supplement 2 |
p. L59-L72
nvt p.
|
artikel
|
| 107 |
Mathematical Models of Cervical Cancer Prevention in the Asia Pacific Region
|
Goldie, Sue J.
|
|
2008
|
26 |
Supplement 2 |
p. M17-M29
nvt p.
|
artikel
|
| 108 |
Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students—Iowa, 2006
|
Marin, Mona
|
|
2008
|
26 |
Supplement 2 |
p. 3601-3607
7 p.
|
artikel
|
| 109 |
Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A
|
Taylor, Claribel P.
|
|
2008
|
26 |
Supplement 2 |
p. 3404-3409
6 p.
|
artikel
|
| 110 |
Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: A multi-regional health economic analysis
|
Rogoza, Raina M.
|
|
2008
|
26 |
Supplement 2 |
p. F46-F58
nvt p.
|
artikel
|
| 111 |
Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2
|
Zhang, Hong-Ying
|
|
2008
|
26 |
Supplement 2 |
p. 769-777
9 p.
|
artikel
|
| 112 |
Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3kDa confers protection against Clonorchis sinensis
|
Zhou, Zhenwen
|
|
2008
|
26 |
Supplement 2 |
p. 1817-1825
9 p.
|
artikel
|
| 113 |
Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies
|
Zhang, Shoufeng
|
|
2008
|
26 |
Supplement 2 |
p. 345-350
6 p.
|
artikel
|
| 114 |
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
|
Cuzick, Jack
|
|
2008
|
26 |
Supplement 2 |
p. K29-K41
nvt p.
|
artikel
|
| 115 |
Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice
|
Istrate, Claudia
|
|
2008
|
26 |
Supplement 2 |
p. 4594-4601
8 p.
|
artikel
|
| 116 |
Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes
|
Dai, Kaifan
|
|
2008
|
26 |
Supplement 2 |
p. 5062-5071
10 p.
|
artikel
|
| 117 |
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
|
Kester, Kent E.
|
|
2008
|
26 |
Supplement 2 |
p. 2191-2202
12 p.
|
artikel
|
| 118 |
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
|
Nolan, Terry M.
|
|
2008
|
26 |
Supplement 2 |
p. 4160-4167
8 p.
|
artikel
|
| 119 |
Phenotypic changes in the Japanese encephalitis virus after one passage in Neuro-2a cells: Generation of attenuated strains of the virus
|
Chiou, Shyan-Song
|
|
2007
|
26 |
Supplement 2 |
p. 15-23
9 p.
|
artikel
|
| 120 |
Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses
|
Zhang, Yongxin
|
|
2008
|
26 |
Supplement 2 |
p. 614-622
9 p.
|
artikel
|
| 121 |
Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-β production
|
Elias, Daniel
|
|
2008
|
26 |
Supplement 2 |
p. 3897-3902
6 p.
|
artikel
|
| 122 |
Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins
|
Fort, M.
|
|
2008
|
26 |
Supplement 2 |
p. 1063-1071
9 p.
|
artikel
|
| 123 |
Potentiation of an anthrax DNA vaccine with electroporation
|
Luxembourg, A.
|
|
2008
|
26 |
Supplement 2 |
p. 5216-5222
7 p.
|
artikel
|
| 124 |
Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data
|
Bailleux, F.
|
|
2008
|
26 |
Supplement 2 |
p. 3903-3908
6 p.
|
artikel
|
| 125 |
Prevention of Coxiella burnetii shedding in infected dairy herds using a phase I C. burnetii inactivated vaccine
|
Guatteo, Raphaël
|
|
2008
|
26 |
Supplement 2 |
p. 4320-4328
9 p.
|
artikel
|
| 126 |
Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model
|
Cazorla, Silvia I.
|
|
2008
|
26 |
Supplement 2 |
p. 1999-2009
11 p.
|
artikel
|
| 127 |
Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs
|
Zhang, Wei
|
|
2008
|
26 |
Supplement 2 |
p. 3655-3661
7 p.
|
artikel
|
| 128 |
Protection of chickens from fowl cholera by vaccination with recombinant adhesive protein of Pasteurella multocida
|
Sthitmatee, Nattawooti
|
|
2008
|
26 |
Supplement 2 |
p. 2398-2407
10 p.
|
artikel
|
| 129 |
Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin
|
Tsuji, Takao
|
|
2008
|
26 |
Supplement 2 |
p. 469-476
8 p.
|
artikel
|
| 130 |
Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle
|
Chang, Byoung Sun
|
|
2008
|
26 |
Supplement 2 |
p. 2081-2091
11 p.
|
artikel
|
| 131 |
Protective immunity induced by rPb27 of Paracoccidioides brasiliensis
|
Reis, B.S.
|
|
2008
|
26 |
Supplement 2 |
p. 5461-5469
9 p.
|
artikel
|
| 132 |
Protective Th1 immune responses against chronic toxoplasmosis induced by a protein–protein vaccine combination but not by its DNA–protein counterpart
|
Jongert, E.
|
|
2008
|
26 |
Supplement 2 |
p. 5289-5295
7 p.
|
artikel
|
| 133 |
Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 Hookworm Vaccine in unexposed adults
|
Bethony, Jeffrey M.
|
|
2008
|
26 |
Supplement 2 |
p. 2408-2417
10 p.
|
artikel
|
| 134 |
Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice
|
Xu, Juan
|
|
2008
|
26 |
Supplement 2 |
p. 4519-4525
7 p.
|
artikel
|
| 135 |
Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2
|
Kixmöller, Marion
|
|
2008
|
26 |
Supplement 2 |
p. 3443-3451
9 p.
|
artikel
|
| 136 |
Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
|
Almonte, Maribel
|
|
2008
|
26 |
Supplement 2 |
p. L16-L36
nvt p.
|
artikel
|
| 137 |
Role of different genes in the CS6 operon for surface expression of Enterotoxigenic Escherichia coli colonization factor CS6
|
Tobias, Joshua
|
|
2008
|
26 |
Supplement 2 |
p. 5373-5380
8 p.
|
artikel
|
| 138 |
Rotavirus epidemiology: The Asian Rotavirus Surveillance Network
|
Nelson, E.A.S.
|
|
2008
|
26 |
Supplement 2 |
p. 3192-3196
5 p.
|
artikel
|
| 139 |
Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations
|
Adam, D.
|
|
2008
|
26 |
Supplement 2 |
p. 5944-5951
8 p.
|
artikel
|
| 140 |
Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age
|
Belshe, Robert B.
|
|
2008
|
26 |
Supplement 2 |
p. D10-D16
nvt p.
|
artikel
|
| 141 |
Safety and immunogenicity of a DTaP-IPVVero (serum-free) combination vaccine in comparison to DTaP-IPVMkc when administered simultaneously with Haemophilus influenzae type b conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age
|
Pietrzyk, Jacek J.
|
|
2008
|
26 |
Supplement 2 |
p. 5296-5303
8 p.
|
artikel
|
| 142 |
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children
|
Nolan, Terry
|
|
2008
|
26 |
Supplement 2 |
p. 6383-6391
9 p.
|
artikel
|
| 143 |
Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar™): Primary dosing series in healthy Chinese infants
|
Li, Rong Cheng
|
|
2008
|
26 |
Supplement 2 |
p. 2260-2269
10 p.
|
artikel
|
| 144 |
Safety evaluation of pulmonary influenza vaccination in healthy and “asthmatic” mice
|
Minne, Antoine
|
|
2008
|
26 |
Supplement 2 |
p. 2360-2368
9 p.
|
artikel
|
| 145 |
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines
|
Prymula, Roman
|
|
2008
|
26 |
Supplement 2 |
p. 4563-4570
8 p.
|
artikel
|
| 146 |
Scalable culture systems using different cell lines for the production of Peste des Petits ruminants vaccine
|
Silva, Ana Carina
|
|
2008
|
26 |
Supplement 2 |
p. 3305-3311
7 p.
|
artikel
|
| 147 |
Sexual dimorphism of humoral immunity with human vaccines
|
Cook, Ian Francis
|
|
2008
|
26 |
Supplement 2 |
p. 3551-3555
5 p.
|
artikel
|
| 148 |
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age
|
Block, Stan L.
|
|
2008
|
26 |
Supplement 2 |
p. 4940-4946
7 p.
|
artikel
|
| 149 |
Strategies for financial sustainability of immunization programs: A review of the strategies from 50 national immunization program financial sustainability plans
|
Kamara, Lidija
|
|
2008
|
26 |
Supplement 2 |
p. 6717-6726
10 p.
|
artikel
|
| 150 |
Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia
|
Borkowsky, William
|
|
2008
|
26 |
Supplement 2 |
p. 3086-3089
4 p.
|
artikel
|
| 151 |
The antifertility effects of DNA vaccine-induced immune responses against uroguanylin
|
Sun, Jing
|
|
2008
|
26 |
Supplement 2 |
p. 3696-3704
9 p.
|
artikel
|
| 152 |
The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines
|
Thompson, Joseph M.
|
|
2008
|
26 |
Supplement 2 |
p. 4998-5003
6 p.
|
artikel
|
| 153 |
The cost-effectiveness of typhoid Vi vaccination programs: Calculations for four urban sites in four Asian countries
|
Cook, Joseph
|
|
2008
|
26 |
Supplement 2 |
p. 6305-6316
12 p.
|
artikel
|
| 154 |
The demand for a dengue vaccine: A contingent valuation survey in Metro Manila
|
Palanca-Tan, Rosalina
|
|
2008
|
26 |
Supplement 2 |
p. 914-923
10 p.
|
artikel
|
| 155 |
The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis
|
Araujo, Zaida
|
|
2008
|
26 |
Supplement 2 |
p. 5575-5581
7 p.
|
artikel
|
| 156 |
The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex
|
Fachinger, Vicky
|
|
2008
|
26 |
Supplement 2 |
p. 1488-1499
12 p.
|
artikel
|
| 157 |
The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10
|
Lu, Xiao-ling
|
|
2008
|
26 |
Supplement 2 |
p. 5352-5357
6 p.
|
artikel
|
| 158 |
The epidemiology of mumps in Italy
|
Gabutti, G.
|
|
2008
|
26 |
Supplement 2 |
p. 2906-2911
6 p.
|
artikel
|
| 159 |
The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination
|
Chesson, Harrell W.
|
|
2008
|
26 |
Supplement 2 |
p. 4513-4518
6 p.
|
artikel
|
| 160 |
Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma
|
Toomey, Deirdre
|
|
2008
|
26 |
Supplement 2 |
p. 3540-3549
10 p.
|
artikel
|
| 161 |
The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods
|
Wang, Shixia
|
|
2008
|
26 |
Supplement 2 |
p. 2100-2110
11 p.
|
artikel
|
| 162 |
The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand
|
Stehr-Green, Paul
|
|
2008
|
26 |
Supplement 2 |
p. 739-742
4 p.
|
artikel
|
| 163 |
Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa offers long-lasting protection against experimental visceral leishmaniasis
|
Kumari, Shraddha
|
|
2008
|
26 |
Supplement 2 |
p. 5700-5711
12 p.
|
artikel
|
| 164 |
Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report
|
But, David Yiu-Kuen
|
|
2008
|
26 |
Supplement 2 |
p. 6587-6591
5 p.
|
artikel
|
| 165 |
Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies
|
De Filette, Marina
|
|
2008
|
26 |
Supplement 2 |
p. 6503-6507
5 p.
|
artikel
|
| 166 |
Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands
|
Meerveld-Eggink, A.
|
|
2008
|
26 |
Supplement 2 |
p. 6975-6979
5 p.
|
artikel
|
| 167 |
Vaccination with recombinant Mycobacterium avium subsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challenge
|
Kathaperumal, Kumanan
|
|
2008
|
26 |
Supplement 2 |
p. 1652-1663
12 p.
|
artikel
|
| 168 |
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
|
Vandepapelière, Pierre
|
|
2008
|
26 |
Supplement 2 |
p. 1375-1386
12 p.
|
artikel
|
Tijdschrift beschrijving